The Lowdown on Cancer focuses on the impact of cancer on lives and on the things that give us hope. From the pain of learning you have cancer to innovative new treatments offered by the best and brightest, we’ll give you the Lowdown.
Yes, cancer sucks. But you are not alone. And we are not without hope!
"We know that 50% of humans will have cancer at some time in their life." Well if that wasn't enough of a gut punch, wait for this statistic: Of those people with cancer, 50% will be diagnosed with advanced tumors. Which means treatment options may be...
Our latest innovator bucks the trend, as a "for-profit, social impact, health tech startup." The cancer journey is overwhelming for patients and caregivers. And while many people struggle to advocate for themselves and their loved ones after a cancer...
Over-diagnosis or under-treatment? Dr. Ajay Bhatnagar talks about how diagnostic technologies are moving towards personalization to improve outcomes, and the anticipated wave of late-stage cancers coming as a result of the COVID pandemic....
Meet Michael Moore, CEO & Co-Founder of Pathware. Michael's very personal experiences with cancer and delayed diagnoses fueled his passion to improve the world of medical technology. https://youtu.be/Pj94yvRIsCQ
“I was born in Minneapolis, early, with a birth defect called spina bifida. That really didn’t affect much of my growing up, except for a few surgeries as I was growing, and one immediately following my birth to close the hole in my spine. Other than...
Meet Greg O'Ryan Johnson, Venture Scout Associate. In his role at the CANCER FUND, Greg contributes by evaluating early stage companies through due diligence and analytical processes. Greg’s mission while at the CANCER FUND is to help entrepreneurs bring...
Ann and Blobdry give an update and look forward to our August focus on Access to Care. https://youtu.be/OtsbTs_HswU
What are the barriers and what does it meant to be "underserved"? The answers might surprise you. https://youtu.be/V6WTZJxr8ag
Ann and Dr. Margaret Kirkegaard discuss how innovations can help when a patient is unable to see their healthcare professional face to face. https://youtu.be/t1wRlr7lYFM
Ann Low interviews Allergy and Immunology specialist, Dr. Michael Manning. In this interview, Dr. Manning shares his experience with adding Telehealth to his practice and his feelings as someone who had never utilized it prior to COVID- 19....
Ann is joined by James Bates, CEO of the healthcare automation innovation known as AdviNow Medical. Listen in as he shares the exciting changes that artificial intelligence brings to the future of healthcare. https://youtu.be/M-7hCKTfpDM
Your voice makes a difference in the innovation that CANCER FUND supports. Let’s talk about how to solve this access to care problem. https://youtu.be/GMsXMdnhkiw
We get the opportunity to answer a tough question from a Facebook Friend (Thank you for asking, Susan!) https://youtu.be/wh9etXCf7zg
View our 9/17 Community Forum and learn how CANCER FUND is working to improve Access to Care! https://youtu.be/JC8nEenusEE
What is the “Valley of Death” and how do companies get over it? https://youtu.be/sg3LNCSlEAo
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.